{"id":"licensed-covid-19-vaccine","safety":{"commonSideEffects":[{"effect":"Headache","drugRate":"11.6%","placeboRate":"","totalAtRisk":19955,"totalAffected":2314,"trialsReporting":4},{"effect":"Injection site pain","drugRate":"10.2%","placeboRate":"","totalAtRisk":19791,"totalAffected":2012,"trialsReporting":2},{"effect":"Fatigue","drugRate":"9.5%","placeboRate":"","totalAtRisk":19955,"totalAffected":1897,"trialsReporting":4},{"effect":"Myalgia","drugRate":"8.7%","placeboRate":"","totalAtRisk":19955,"totalAffected":1731,"trialsReporting":4},{"effect":"Chills","drugRate":"7.3%","placeboRate":"","totalAtRisk":19791,"totalAffected":1443,"trialsReporting":2},{"effect":"Pyrexia","drugRate":"6.6%","placeboRate":"","totalAtRisk":19795,"totalAffected":1307,"trialsReporting":3},{"effect":"Fatigue (FATIGUE)","drugRate":"48.6%","placeboRate":"","totalAtRisk":623,"totalAffected":303,"trialsReporting":3},{"effect":"Injection site pain (PAIN)","drugRate":"73.5%","placeboRate":"","totalAtRisk":309,"totalAffected":227,"trialsReporting":1},{"effect":"Headache (HEADACHE)","drugRate":"35.2%","placeboRate":"","totalAtRisk":623,"totalAffected":219,"trialsReporting":3},{"effect":"Chills (CHILLS)","drugRate":"23.6%","placeboRate":"","totalAtRisk":623,"totalAffected":147,"trialsReporting":3},{"effect":"Myalgia (MUSCLE PAIN)","drugRate":"36.9%","placeboRate":"","totalAtRisk":309,"totalAffected":114,"trialsReporting":1},{"effect":"Injection site pain (PAIN AT THE INJECTION SITE) left deltoid","drugRate":"56.2%","placeboRate":"","totalAtRisk":160,"totalAffected":90,"trialsReporting":1},{"effect":"Injection site pain (PAIN AT THE INJECTION SITE)","drugRate":"57.1%","placeboRate":"","totalAtRisk":154,"totalAffected":88,"trialsReporting":1},{"effect":"Arthralgia (JOINT PAIN)","drugRate":"24.9%","placeboRate":"","totalAtRisk":309,"totalAffected":77,"trialsReporting":1},{"effect":"Diarrhoea (DIARRHEA)","drugRate":"12.0%","placeboRate":"","totalAtRisk":623,"totalAffected":75,"trialsReporting":3},{"effect":"Injection site erythema (REDNESS)","drugRate":"12.1%","placeboRate":"","totalAtRisk":463,"totalAffected":56,"trialsReporting":2},{"effect":"Pyrexia (FEVER)","drugRate":"8.3%","placeboRate":"","totalAtRisk":623,"totalAffected":52,"trialsReporting":3},{"effect":"Injection site swelling (SWELLING)","drugRate":"10.4%","placeboRate":"","totalAtRisk":463,"totalAffected":48,"trialsReporting":2},{"effect":"Upper respiratory tract infection","drugRate":"6.6%","placeboRate":"","totalAtRisk":716,"totalAffected":47,"trialsReporting":3},{"effect":"Myalgia (NEW OR WORSENED MUSCLE PAIN)","drugRate":"13.1%","placeboRate":"","totalAtRisk":314,"totalAffected":41,"trialsReporting":2},{"effect":"Arthralgia (NEW OR WORSENED JOINT PAIN)","drugRate":"8.0%","placeboRate":"","totalAtRisk":314,"totalAffected":25,"trialsReporting":2},{"effect":"COVID-19","drugRate":"2.3%","placeboRate":"","totalAtRisk":1030,"totalAffected":24,"trialsReporting":5},{"effect":"Injection site pain (PAIN AT THE INJECTION SITE) right deltoid","drugRate":"11.9%","placeboRate":"","totalAtRisk":160,"totalAffected":19,"trialsReporting":1},{"effect":"Vomiting (VOMITING)","drugRate":"2.4%","placeboRate":"","totalAtRisk":623,"totalAffected":15,"trialsReporting":3},{"effect":"Injection site swelling (SWELLING) left deltoid","drugRate":"9.4%","placeboRate":"","totalAtRisk":160,"totalAffected":15,"trialsReporting":1},{"effect":"Injection site erythema (REDNESS) left deltoid","drugRate":"8.8%","placeboRate":"","totalAtRisk":160,"totalAffected":14,"trialsReporting":1},{"effect":"Malaise","drugRate":"50.0%","placeboRate":"","totalAtRisk":8,"totalAffected":4,"trialsReporting":2},{"effect":"Vaccination site pain","drugRate":"100.0%","placeboRate":"","totalAtRisk":4,"totalAffected":4,"trialsReporting":1},{"effect":"Rash","drugRate":"0.9%","placeboRate":"","totalAtRisk":318,"totalAffected":3,"trialsReporting":3},{"effect":"Arthralgia","drugRate":"1.2%","placeboRate":"","totalAtRisk":168,"totalAffected":2,"trialsReporting":3},{"effect":"Injection site erythema (REDNESS) right deltoid","drugRate":"1.2%","placeboRate":"","totalAtRisk":160,"totalAffected":2,"trialsReporting":1},{"effect":"Injection site swelling (SWELLING) right deltoid","drugRate":"1.2%","placeboRate":"","totalAtRisk":160,"totalAffected":2,"trialsReporting":1},{"effect":"Vaccination site induration","drugRate":"50.0%","placeboRate":"","totalAtRisk":4,"totalAffected":2,"trialsReporting":1},{"effect":"Vessel puncture site haemorrhage","drugRate":"0.6%","placeboRate":"","totalAtRisk":160,"totalAffected":1,"trialsReporting":1},{"effect":"Inguinal hernia","drugRate":"0.6%","placeboRate":"","totalAtRisk":160,"totalAffected":1,"trialsReporting":1},{"effect":"Nausea","drugRate":"0.6%","placeboRate":"","totalAtRisk":164,"totalAffected":1,"trialsReporting":2},{"effect":"Norovirus infection","drugRate":"0.6%","placeboRate":"","totalAtRisk":160,"totalAffected":1,"trialsReporting":1},{"effect":"Road traffic accident","drugRate":"0.6%","placeboRate":"","totalAtRisk":160,"totalAffected":1,"trialsReporting":1},{"effect":"Hypercholesterolaemia","drugRate":"0.6%","placeboRate":"","totalAtRisk":160,"totalAffected":1,"trialsReporting":1},{"effect":"Type 2 diabetes mellitus","drugRate":"0.6%","placeboRate":"","totalAtRisk":164,"totalAffected":1,"trialsReporting":2},{"effect":"Vitamin D deficiency","drugRate":"0.6%","placeboRate":"","totalAtRisk":160,"totalAffected":1,"trialsReporting":1},{"effect":"Costochondritis","drugRate":"0.6%","placeboRate":"","totalAtRisk":160,"totalAffected":1,"trialsReporting":1},{"effect":"Musculoskeletal chest pain","drugRate":"0.6%","placeboRate":"","totalAtRisk":160,"totalAffected":1,"trialsReporting":1},{"effect":"Oropharyngeal pain","drugRate":"0.6%","placeboRate":"","totalAtRisk":164,"totalAffected":1,"trialsReporting":2},{"effect":"Skin laceration","drugRate":"25.0%","placeboRate":"","totalAtRisk":4,"totalAffected":1,"trialsReporting":1},{"effect":"Diarrhoea","drugRate":"0.0%","placeboRate":"","totalAtRisk":725,"totalAffected":0,"trialsReporting":5},{"effect":"Dyslipidaemia","drugRate":"0.0%","placeboRate":"","totalAtRisk":403,"totalAffected":0,"trialsReporting":1},{"effect":"Hypertension","drugRate":"0.0%","placeboRate":"","totalAtRisk":567,"totalAffected":0,"trialsReporting":3},{"effect":"Hypertensive urgency","drugRate":"0.0%","placeboRate":"","totalAtRisk":403,"totalAffected":0,"trialsReporting":1},{"effect":"Lymphadenopathy","drugRate":"0.0%","placeboRate":"","totalAtRisk":164,"totalAffected":0,"trialsReporting":2}]},"_chembl":null,"_dailymed":null,"mechanism":{"target":"S","drugClass":"mRNA vaccine","explanation":"This mRNA vaccine delivers genetic instructions to your cells, which then produce a piece of the SARS-CoV-2 spike protein. The immune system recognizes this protein as foreign and mounts a defense, preparing to fight off future infections.","oneSentence":"The vaccine uses mRNA to instruct cells to produce a harmless piece of the spike protein, triggering an immune response."},"_scrapedAt":"2026-03-28T04:11:21.767Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_validation":{"fieldsValidated":1,"lastValidatedAt":"2026-04-20T08:53:46.361047+00:00","fieldsConflicting":0,"overallConfidence":0.95},"trialDetails":[{"nctId":"NCT07464314","phase":"PHASE1","title":"A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults","status":"RECRUITING","sponsor":"GlaxoSmithKline","startDate":"2026-03-09","conditions":"Influenza, Human+COVID-19","enrollment":225},{"nctId":"NCT05876377","phase":"","title":"Use and Effectiveness of COVID-19 Vaccines Using State Vaccine Registries and Insurance Claims Data","status":"ACTIVE_NOT_RECRUITING","sponsor":"Pfizer","startDate":"2023-10-23","conditions":"SARS-CoV-2, COVID-19, Post-Acute COVID-19 Syndrome","enrollment":1},{"nctId":"NCT06821061","phase":"PHASE1, PHASE2","title":"A Study to Learn About How the Flu and COVID-19 Vaccines Act in Healthy People","status":"COMPLETED","sponsor":"BioNTech SE","startDate":"2025-02-10","conditions":"Influenza, COVID-19 (Coronavirus Disease 2019)","enrollment":2650},{"nctId":"NCT06279871","phase":"PHASE3","title":"Immunogenicity and Safety Study of Self-amplifying mRNA COVID-19 Vaccine Administered With Influenza Vaccines in Adults","status":"COMPLETED","sponsor":"Arcturus Therapeutics, Inc.","startDate":"2024-03-27","conditions":"COVID-19","enrollment":1514},{"nctId":"NCT06178991","phase":"PHASE3","title":"A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Combined Modified RNA Vaccine Candidate Against COVID-19 and Influenza.","status":"COMPLETED","sponsor":"BioNTech SE","startDate":"2023-12-20","conditions":"Influenza, COVID-19","enrollment":8795},{"nctId":"NCT06694389","phase":"PHASE3","title":"Study to Investigate the Immunogenicity, Reactogenicity, and Safety of mRNA-1083 Vaccine (SARS-CoV-2 [COVID-19] and Influenza) in Adults ≥50 Years of Age","status":"COMPLETED","sponsor":"ModernaTX, Inc.","startDate":"2024-11-18","conditions":"COVID-19, Influenza","enrollment":2457},{"nctId":"NCT06441968","phase":"PHASE1","title":"Safety and Immunogenicity Trial of MPV/S-2P SARS-CoV-2 Vaccine in Adults","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2024-07-01","conditions":"COVID-19","enrollment":60},{"nctId":"NCT06237049","phase":"PHASE2","title":"A Study to Learn About a Combined COVID-19 and Influenza Shot in Healthy Adults","status":"COMPLETED","sponsor":"Pfizer","startDate":"2024-01-31","conditions":"Influenza, Human, SARS-CoV-2 Infection, COVID-19","enrollment":644},{"nctId":"NCT06680375","phase":"PHASE1","title":"A Study of an Investigational Flu Seasonal/SARS-CoV-2 Combination Vaccine in Adults","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2024-11-11","conditions":"COVID-19","enrollment":106},{"nctId":"NCT06683352","phase":"PHASE1, PHASE2","title":"A Study to Learn About Flu and COVID-19 Vaccine Responses in Healthy People","status":"COMPLETED","sponsor":"BioNTech SE","startDate":"2024-11-11","conditions":"Influenza,Human, COVID-19","enrollment":1353},{"nctId":"NCT06147063","phase":"PHASE1","title":"A Randomized Trial Evaluating a mRNA-VLP Vaccine's Immunogenicity and Safety for COVID-19","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2023-11-27","conditions":"COVID-19, SARS-CoV-2 Infection","enrollment":243},{"nctId":"NCT06354998","phase":"PHASE3","title":"A Study of an Investigational mRNA-1273.815 COVID-19 Vaccine in Previously Vaccinated Adults","status":"COMPLETED","sponsor":"ModernaTX, Inc.","startDate":"2024-04-08","conditions":"SARS-CoV-2","enrollment":217},{"nctId":"NCT04776317","phase":"PHASE1","title":"Chimpanzee Adenovirus and Self-Amplifying mRNA Prime-Boost Prophylactic Vaccines Against SARS-CoV-2 in Healthy Adults","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2021-03-25","conditions":"COVID-19","enrollment":81},{"nctId":"NCT04583995","phase":"PHASE3","title":"A Study Looking at the Effectiveness, Immune Response, and Safety of a COVID-19 Vaccine in Adults in the United Kingdom","status":"COMPLETED","sponsor":"Novavax","startDate":"2020-09-28","conditions":"SARS-CoV-2 Infection, COVID-19","enrollment":15185},{"nctId":"NCT05886777","phase":"PHASE2","title":"A Study to Learn About Two or More Vaccines That Are Put Together as One Shot Against Infectious Lung Illnesses, Including COVID-19 and Respiratory Syncytial Virus (RSV).","status":"COMPLETED","sponsor":"Pfizer","startDate":"2023-06-05","conditions":"Healthy Participants","enrollment":1142},{"nctId":"NCT05925127","phase":"PHASE2, PHASE3","title":"Phase 2/3 Heterologous Boosting Study With Different Dose Levels of Monovalent SARS-CoV-2 rS Vaccines","status":"COMPLETED","sponsor":"Novavax","startDate":"2023-10-16","conditions":"COVID-19","enrollment":994},{"nctId":"NCT05212792","phase":"","title":"Genomics and COVID-19 Vaccine Adverse Events","status":"RECRUITING","sponsor":"University of British Columbia","startDate":"2022-06-24","conditions":"Vaccine Adverse Reaction","enrollment":6325},{"nctId":"NCT05212974","phase":"","title":"COVID-19 Vaccine Hesitancy Among Nurses","status":"COMPLETED","sponsor":"National Taiwan University Hospital","startDate":"2022-02-22","conditions":"COVID-19, Vaccine Hesitancy, Vaccination","enrollment":4258},{"nctId":"NCT05031468","phase":"","title":"Multisite Observational Maternal and Infant Study for COVID-19","status":"COMPLETED","sponsor":"Emory University","startDate":"2021-07-06","conditions":"COVID-19","enrollment":562},{"nctId":"NCT04652102","phase":"PHASE2, PHASE3","title":"A Phase 2b/3, Randomized, Observer-Blinded, Placebo-Controlled, Multicenter Clinical Study Evaluating the Efficacy and Safety of Investigational SARS-CoV-2 mRNA Vaccine CVnCoV in Adults 18 Years of Age and Older","status":"COMPLETED","sponsor":"CureVac","startDate":"2020-12-11","conditions":"Covid19, SARS-CoV-2","enrollment":39680},{"nctId":"NCT04805125","phase":"PHASE3","title":"Immunocompromised Swiss Cohorts Based Trial Platform","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2021-04-19","conditions":"Immunocompromised Patients","enrollment":610},{"nctId":"NCT05272605","phase":"PHASE1","title":"Safety and Immune Response of Adjuvanted SARS-CoV-2 (COVID-19) Beta Variant RBD Recombinant Protein (DoCo-Pro-RBD-1 + MF59®) and mRNA (MIPSCo-mRNA-RBD-1) Vaccines in Healthy Adults","status":"COMPLETED","sponsor":"University of Melbourne","startDate":"2022-04-05","conditions":"SARS-CoV-2","enrollment":76},{"nctId":"NCT05614245","phase":"PHASE1","title":"Safety, Tolerability, and Immunogenicity of Trivalent Coronavirus Vaccine Candidate VBI-2901e With E6020 Adjuvant","status":"WITHDRAWN","sponsor":"VBI Vaccines Inc.","startDate":"2023-03","conditions":"COVID-19, Coronavirus Infections","enrollment":""},{"nctId":"NCT05548439","phase":"PHASE1","title":"Safety, Tolerability, and Immunogenicity of Trivalent Coronavirus Vaccine Candidate VBI-2901a","status":"UNKNOWN","sponsor":"VBI Vaccines Inc.","startDate":"2022-10-05","conditions":"COVID-19, Coronavirus Infections","enrollment":103},{"nctId":"NCT04537663","phase":"PHASE4","title":"Prevention Of Respiratory Tract Infection And Covid-19 Through BCG Vaccination In Vulnerable Older Adults","status":"COMPLETED","sponsor":"UMC Utrecht","startDate":"2020-09-07","conditions":"Respiratory Tract Infections, Covid19","enrollment":6112},{"nctId":"NCT05494047","phase":"PHASE3","title":"Phase Ⅲ, Clinical Trial to Compare an Inactivated Quadrivalent Influenza Vaccine and a Licensed Vaccine in Chile","status":"UNKNOWN","sponsor":"Pontificia Universidad Catolica de Chile","startDate":"2022-07-14","conditions":"Influenza, Vaccines","enrollment":1600},{"nctId":"NCT05252910","phase":"","title":"Specimen Collection Study From Coronavirus Disease 2019 (COVID-19) Vaccinated Adults and Adolescents","status":"TERMINATED","sponsor":"Pharm-Olam, LLC","startDate":"2022-01-01","conditions":"COVID-19","enrollment":33},{"nctId":"NCT04569383","phase":"PHASE1","title":"Safety and Immunogenicity of the Candidate Vaccine MVA-SARS-2-S and a Booster Vaccination With a Licensed Vaccine Against COVID-19","status":"COMPLETED","sponsor":"Universitätsklinikum Hamburg-Eppendorf","startDate":"2020-10-05","conditions":"Covid19","enrollment":30},{"nctId":"NCT04848467","phase":"PHASE3","title":"COVID-19: A Trial Studying the SARS-CoV-2 mRNA Vaccine CVnCoV to Learn About the Immune Response, the Safety, and the Degree of Typical Vaccination Reactions When CVnCoV is Given at the Same Time as a Flu Vaccine Compared to When the Vaccines Are Separately Given in Adults 60 Years of Age and Older","status":"WITHDRAWN","sponsor":"Bayer","startDate":"2021-10-01","conditions":"SARS-CoV-2 Infection, Coronavirus Disease 2019 (COVID-19)","enrollment":""}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":3,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_1","status":"active","brandName":"Licensed COVID-19 Vaccine","genericName":"Licensed COVID-19 Vaccine","companyName":"BioNTech SE","companyId":"biontech-se","modality":"Biologic","firstApprovalDate":"","aiSummary":"","enrichmentLevel":5,"visitCount":8,"trialStats":{"total":21,"withResults":7},"validation":{"fieldsValidated":1,"lastValidatedAt":"2026-04-20T08:53:46.361047+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":false,"safety":true,"trials":true,"score":3}}